To evaluate the tolerability and safety of inhaled prochlorperazine To evaluate the
pharmacokinetics of inhaled prochlorperazine
- Subjects will be male or female subjects between the ages 18 to 45 years, inclusive
in good general health as determined by medical history, physical examination,
12-lead ECG, spirometry, blood chemistry profile, hematology, urinalysis and in the
opinion of the Principal Investigator.
- Subjects with a known history of allergy or intolerance to phenothiazines or related
drugs or who have any disease, by history, physical examination, or laboratory
abnormalities that in the investigator's opinion, would present undue risk to the
subject, or may confound the interpretation of study results.